Manufacturers Life Insurance Company, The Emergent Bio Solutions Inc. Transaction History

Manufacturers Life Insurance Company, The

$108 Billion
Q3 2024

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$1.5 - $3.41 $17,406 - $39,569	11,604 New	11,604 $29,000
Q2 2023 Aug 11, 2023	BUY	$7.35 - $13.21 $2,432 - $4,372	331 Added 1.6%	20,955 $154,000
Q1 2023 May 15, 2023	SELL	$7.79 - $16.29 $5,086 - $10,637	-653 Reduced 3.17%	19,971 $206,000
Q4 2022 Aug 11, 2023	BUY	$11.0 - $21.45 $6,160 - $12,012	560 Added 2.79%	20,624 $243,000
Q4 2022 Feb 13, 2023	BUY	$11.0 - $21.45 $6,160 - $12,012	560 Added 2.79%	20,624 $243,000
Q3 2022 Aug 11, 2023	SELL	$20.09 - $35.8 $7,674 - $13,675	-382 Reduced 1.87%	20,064 $421,000
Q3 2022 Nov 03, 2022	SELL	$20.09 - $35.8 $7,674 - $13,675	-382 Reduced 1.87%	20,064 $421,000
Q2 2022 Aug 11, 2023	SELL	$27.42 - $43.63 $7.52 Million - $12 Million	-274,349 Reduced 93.06%	20,446 $634,000
Q2 2022 Aug 15, 2022	SELL	$27.42 - $43.63 $7.52 Million - $12 Million	-274,349 Reduced 93.06%	20,446 $635,000
Q1 2022 Aug 11, 2023	BUY	$36.48 - $52.22 $10 Million - $14.4 Million	274,824 Added 1376.12%	294,795 $12.1 Million
Q1 2022 May 20, 2022	SELL	$36.48 - $52.22 $29.7 Million - $42.5 Million	-812,977 Reduced 73.39%	294,795 $12.1 Million
Q4 2021 Feb 16, 2022	SELL	$33.11 - $55.01 $9.7 Million - $16.1 Million	-292,910 Reduced 20.91%	1,107,772 $48.9 Million
Q3 2021 Nov 12, 2021	BUY	$50.07 - $66.05 $2.41 Million - $3.18 Million	48,100 Added 3.56%	1,400,682 $70.1 Million
Q2 2021 Aug 12, 2021	BUY	$56.61 - $80.46 $8.68 Million - $12.3 Million	153,351 Added 12.79%	1,352,582 $85.2 Million
Q1 2021 May 03, 2021	BUY	$86.23 - $125.19 $10.1 Million - $14.7 Million	117,614 Added 10.87%	1,199,231 $111 Million
Q4 2020 Feb 12, 2021	BUY	$79.17 - $111.47 $14.9 Million - $21 Million	188,179 Added 21.06%	1,081,617 $96.9 Million
Q3 2020 Nov 09, 2020	SELL	$81.91 - $134.94 $6.19 Million - $10.2 Million	-75,574 Reduced 7.8%	893,438 $92.3 Million
Q2 2020 Aug 10, 2020	BUY	$54.33 - $89.52 $3.62 Million - $5.97 Million	66,695 Added 7.39%	969,012 $73.1 Million
Q1 2020 May 15, 2020	BUY	$49.34 - $68.76 $14.2 Million - $19.7 Million	287,074 Added 46.66%	902,317 $52.2 Million
Q4 2019 Feb 14, 2020	BUY	$51.21 - $59.06 $6.05 Million - $6.98 Million	118,129 Added 23.76%	615,243 $33.2 Million
Q3 2019 Nov 12, 2019	SELL	$40.6 - $57.2 $1.44 Million - $2.02 Million	-35,376 Reduced 6.64%	497,114 $25.4 Million
Q2 2019 Aug 14, 2019	BUY	$39.92 - $53.86 $2.33 Million - $3.14 Million	58,243 Added 12.28%	532,490 $25.7 Million
Q1 2019 May 13, 2019	BUY	$48.23 - $66.16 $21.6 Million - $29.6 Million	446,886 Added 1633.3%	474,247 $24 Million
Q4 2018 Feb 14, 2019	SELL	$55.63 - $73.24 $85,892 - $113,082	-1,544 Reduced 5.34%	27,361 $1.62 Million
Q3 2018 Nov 14, 2018	SELL	$52.05 - $66.51 $215,434 - $275,284	-4,139 Reduced 12.53%	28,905 $1.9 Million
Q2 2018 Aug 14, 2018	BUY	$48.33 - $55.64 $367,066 - $422,585	7,595 Added 29.84%	33,044 $1.67 Million
Q1 2018 May 15, 2018	SELL	$44.44 - $54.39 $29.3 Million - $35.8 Million	-659,088 Reduced 96.28%	25,449 $1.34 Million
Q4 2017 Feb 08, 2018	BUY	$37.77 - $47.75 $1.33 Million - $1.69 Million	35,317 Added 5.44%	684,537 $31.8 Million
Q3 2017 Nov 14, 2017	BUY	$34.14 - $40.45 $22.2 Million - $26.3 Million	649,220	649,220 $26.3 Million

Others Institutions Holding EBS

# of Institutions

159

Shares Held

33.7M

Call Options Held

453K

Put Options Held

931K

Black Rock Inc. New York, NY

3.84M
Shares

$36.4 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.4M
Shares

$32.2 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.49M
Shares

$23.6 Million
0.03% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

2.22M
Shares

$21.1 Million
0.0% of portfolio
State Street Corp Boston, MA

1.91M
Shares

$18.1 Million
0.0% of portfolio

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $473M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account